Roundtable Discussion: Pathways to Reimbursement Success in Immuno-Dermatology: Insights from the Reimbursor Perspective
Time: 9:30 am
day: Day Two AM
Details:
- Explore key metrics and data requirements reimbursement bodies prioritize to ensure therapies are deemed clinically and economically viable
- Learn how data informs reimbursement decisions and substantiates long-term value propositions for immuno-dermatology therapies
- Gain insights into harmonizing trial design and endpoints with HTA criteria to address unmet needs
Speakers:
